Arimoclomol

Generic Name
Arimoclomol
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C14H20ClN3O3
CAS Number
289893-25-0
Unique Ingredient Identifier
EUT3557RT5
Background

Arimoclomol is an experimental drug compound developed by CytRx Corporation, a biopharmaceutical company based in Los Angeles, California. The orally administered drug is intended to treat amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, a neurodegenerative disease with no effective treatment.

Indication

Investigated for use/treatment in amyotrophic lateral sclerosis (ALS), diabetes mellitus type 2, neurologic disorders, and neuropathy (diabetic).

Associated Conditions
-
Associated Therapies
-
© Copyright 2024. All Rights Reserved by MedPath